Kontafarma China Holdings Ltd (HK:1312) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Kontafarma China Holdings Limited has issued a clarification regarding an error in the title of Mr. Wang Feifei in their recent announcement. The correct title for Mr. Wang Feifei is ‘President’ rather than ‘Executive President’ as previously stated. The company confirms that apart from this correction, all other details in the original documents remain unchanged.
For further insights into HK:1312 stock, check out TipRanks’ Stock Analysis page.